Related Experiment Video
Updated: May 5, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Precision of a phage susceptibility spot assay assessed with 154 clinical Staphylococcus aureus isolates
Sebastian C Herren1, Christoph L Zink1, Jay Mandrekar2
1Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Abstract:
Lytic phages are a promising consideration to combat recalcitrant bacterial infections. To advance the possibility of using phage therapy in the clinical routine, standardized phage susceptibility testing methods are needed. Here, staphylococcal phage K was tested against 154 periprosthetic joint infection-associated Staphylococcus aureus isolates using a double overlay spot assay in technical and biological triplicates. Individual plaques were assessed using a morphology scoring system ranging from 0 (no plaques) to 4 (large, clear plaques), with scores ≥2 considered indicative of infectivity. Overall, 107 isolates exhibited scores ≥2. The intra-day and inter-day coefficients of variation were 0.9 and 2.5, respectively. Plaque-forming unit per milliliter (PFU/mL) titers correlated with morphology scores (Spearman's ρ = 0.8, P < 0.0001). The results suggest high precision of the described spot assay assessing S. aureus susceptibility to phage K.IMPORTANCEStandardized laboratory assays for assessing phage susceptibility are a prerequisite for clinical implementation of phage therapy. No assay has been denoted a reference standard. Criteria that can be used to assess assay precision and suitability for routine testing are intermediate precision and repeatability. Here, staphylococcal phage K was tested using the double overlay spot assay against 154 periprosthetic joint infection-associated Staphylococcus aureus isolates in technical and biological triplicates. In addition to measuring phage titers, plaque-forming units were assessed with a scoring system. Results indicate high intermediate precision and repeatability of the method described.
Insights
A novel spot assay precisely measures staphylococcal phage K susceptibility in Staphylococcus aureus isolates. This method shows high repeatability, supporting phage therapy
Area of Science:
- Microbiology
- Bacteriology
- Phage Therapy
Background:
- Recalcitrant bacterial infections necessitate novel therapeutic strategies.
- Bacteriophages (phages) offer a promising alternative to antibiotics.
- Standardized methods for phage susceptibility testing are crucial for clinical application.
Purpose of the Study:
- To evaluate the precision and repeatability of a double overlay spot assay for assessing staphylococcal phage K susceptibility.
- To determine the infectivity of phage K against Staphylococcus aureus isolates from periprosthetic joint infections.
Main Methods:
- A double overlay spot assay was employed to test staphylococcal phage K against 154 Staphylococcus aureus isolates.
- Assays were performed in technical and biological triplicates.
- Plaque morphology was scored (0-4), and plaque-forming unit per milliliter (PFU/mL) titers were determined.
Main Results:
- The assay demonstrated high intermediate precision (inter-day coefficient of variation: 2.5) and repeatability (intra-day coefficient of variation: 0.9).
- 107 out of 154 isolates (69.5%) showed significant susceptibility to phage K (morphology score ≥2).
- Plaque-forming unit per milliliter titers strongly correlated with morphology scores (Spearman's ρ = 0.8, P < 0.0001).
Conclusions:
- The described double overlay spot assay exhibits high precision and repeatability for assessing Staphylococcus aureus susceptibility to staphylococcal phage K.
- This standardized method is suitable for routine laboratory testing and supports the clinical implementation of phage therapy.
More Related Videos
12:27Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021